Boots Clinical Trials Supplies

Our Sterile Cell produces ophthalmic and parenteral products in bottles, ampoules, and vials. The Specials facility uses isolator technology to fill small (1+) batches of product, and our main plant uses automatic equipment for medium scale (10,000+) work. Our fully MHRA-approved facilities are ideally suited to the preparation of pre-clinical and Phase I/II/II trials batches.

Activity:

- Clinical Trials
- Contract Manufacturing
- Manufacturing

Product / Technology type(s) covered:

- API / chemicals
- Bio
- Cosmoceuticals
- Devices
- Diagnostics
- Generics
- FP (finished products)
- OTC (over the counter drugs)
- Pharmaceuticals / Therapeutics
- Nutritionals / Vitamins
- Proteins

Therapeutic targets:

- AIDS
- Allergy
- Arthritis / Rheumato
- Asthma
- Cancer
- Cardiovascular
- Central nervous system
- Cough / Cold
- Diabetes
- Infectious Diseases
- Obesity
- Oncology
- Ophthalmology
- Pain
- Respiratory Medicine
- Urology

Markets Covered

a. HeadQuarter: United Kingdom

b. Continent(s) active: Europe , North America , Australia/New-Zealand , Asia , Central/South America , Far East , Near/Middle East , Africa

c. Countries active: UK, France, Germany, Netherlands, Switzerland, USA, Australia

Corporate data:

Number of Employees: >8,000

Turnover:

Amount:	Year:	Currency:
8.5bn	2002	Euro

Year founded: 1849

Stock options:

	Symbol	Exchange
1	BOO	FTSE